Pavlakis N - Search Results

1

The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia.

Oh B, Butow P, Mullan B, Beale P, Pavlakis N, Rosenthal D, Clarke S. Oh B, et al. Among authors: pavlakis n. Asia Pac J Clin Oncol. 2010 Dec;6(4):342-9. doi: 10.1111/j.1743-7563.2010.01329.x. Epub 2010 Oct 26. Asia Pac J Clin Oncol. 2010. PMID: 21114784

2

Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial.

Oh B, Butow P, Mullan B, Clarke S, Beale P, Pavlakis N, Kothe E, Lam L, Rosenthal D. Oh B, et al. Among authors: pavlakis n. Ann Oncol. 2010 Mar;21(3):608-614. doi: 10.1093/annonc/mdp479. Epub 2009 Oct 30. Ann Oncol. 2010. PMID: 19880433 Free PMC article. Clinical Trial.

3

Patient-doctor communication: use of complementary and alternative medicine by adult patients with cancer.

Oh B, Butow P, Mullan B, Clarke S, Tattersall M, Boyer M, Beale P, Vardy J, Pavlakis N, Larke L. Oh B, et al. Among authors: pavlakis n. J Soc Integr Oncol. 2010 Spring;8(2):56-64. J Soc Integr Oncol. 2010. PMID: 20388446

4

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, Clarke SJ. Kao SC, et al. Among authors: pavlakis n. Clin Cancer Res. 2010 Dec 1;16(23):5805-13. doi: 10.1158/1078-0432.CCR-10-2245. Epub 2010 Oct 18. Clin Cancer Res. 2010. PMID: 20956618

5

Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial.

Oh B, Butow PN, Mullan BA, Clarke SJ, Beale PJ, Pavlakis N, Lee MS, Rosenthal DS, Larkey L, Vardy J. Oh B, et al. Among authors: pavlakis n. Support Care Cancer. 2012 Jun;20(6):1235-42. doi: 10.1007/s00520-011-1209-6. Epub 2011 Jun 19. Support Care Cancer. 2012. PMID: 21688163 Clinical Trial.

6

The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine.

Kao SC, Harvie R, Paturi F, Taylor R, Davey R, Abraham R, Clarke S, Marx G, Cullen M, Kerestes Z, Pavlakis N. Kao SC, et al. Among authors: pavlakis n. Lung Cancer. 2012 Feb;75(2):248-54. doi: 10.1016/j.lungcan.2011.06.007. Epub 2011 Jul 16. Lung Cancer. 2012. PMID: 21757252

7

Glycemic index, glycemic load and endometrial cancer risk: results from the Australian National Endometrial Cancer study and an updated systematic review and meta-analysis.

Nagle CM, Olsen CM, Ibiebele TI, Spurdle AB, Webb PM; Astralian National Endometrial Cancer Study Group; Astralian Ovarian Cancer Study Group. Nagle CM, et al. Eur J Nutr. 2013 Mar;52(2):705-15. doi: 10.1007/s00394-012-0376-7. Epub 2012 May 22. Eur J Nutr. 2013. PMID: 22648201 Review.

8

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.

Kao SC, Vardy J, Chatfield M, Corte P, Pavlakis N, Clarke C, van Zandwijk N, Clarke S. Kao SC, et al. Among authors: pavlakis n. Clin Lung Cancer. 2013 Jan;14(1):70-7. doi: 10.1016/j.cllc.2012.03.011. Epub 2012 Jun 1. Clin Lung Cancer. 2013. PMID: 22658812

9

A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancer.

Michael M, Pavlakis N, Clingan P, De Boer R, Johnston M, Clarke S. Michael M, et al. Among authors: pavlakis n. Oncol Rep. 2012 Sep;28(3):763-7. doi: 10.3892/or.2012.1871. Epub 2012 Jun 15. Oncol Rep. 2012. PMID: 22710607 Free PMC article. Clinical Trial.

10

Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.

Clarke SJ, Karapetis CS, Gibbs P, Pavlakis N, Desai J, Michael M, Tebbutt NC, Price TJ, Tabernero J. Clarke SJ, et al. Among authors: pavlakis n. Crit Rev Oncol Hematol. 2013 Feb;85(2):121-35. doi: 10.1016/j.critrevonc.2012.06.001. Epub 2012 Jul 2. Crit Rev Oncol Hematol. 2013. PMID: 22762963 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters